Vishnu Vijay Vijayan

机构：Dalhousie University, Beatrice Hunter Cancer Research Institute

发表论文 8 篇 · 总被引 18 次 · h-index 3

代表论文

• Subversion of kynurenine-induced AHR activation in CD8 T cells by kynureninase-expressing antigen-presenting cells (2026 · Cell Reports · 被引 7)
• Multiprong CD38 targeting to enhance anti-PD1 immune checkpoint blockade efficacy (2024 · OncoImmunology · 被引 4)
• TRPML1 signaling at lysosomes-mitochondria nexus drives triple-negative breast cancer mitophagy, metabolic reprogramming and chemoresistance (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 3)
• THSD4 is a novel mediator of T cell exclusion and anti-PD-1 resistance in hormone receptor-positive breast cancer (2025 · Biomarker Research · 被引 2)
• Targeting Age-Associated Immune Senescence via Nanoparticle-Based Metabolic Reprogramming (2026 · ACS Nano · 被引 1)
• Targeting TRPML3 inhibits proliferation and invasion, and enhances doxorubicin sensitivity by disrupting lysosomal acidification and mitochondrial function in triple-negative breast cancer (2025 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 被引 1)